{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:35:38Z","timestamp":1787654138551,"version":"build-2736575974"},"reference-count":52,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The combination of frequently abnormal hemostatic markers and catastrophic bleeding as seen with variceal hemorrhage has contributed to the longstanding misperception that chronic liver disease (CLD) constitutes a bleeding diathesis. Laboratory studies of hemostasis in liver disease consistently challenge this with global coagulation assays incorporating activation of the protein C pathway demonstrating rebalanced hemostasis. It is now recognized that bleeding in CLD is predominantly secondary to portal hypertension (rather than a coagulopathy) and additionally that these patients are at increased risk of venous thrombosis, particularly in the portal venous system. This narrative review describes the current understanding of hemostasis in liver disease, as well as the periprocedural management of hemostasis and anticoagulation for management of venous thromboembolism in patients with CLD.<\/jats:p>","DOI":"10.1182\/hematology.2021000283","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:16:51Z","timestamp":1639138611000},"page":"485-491","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Rebalanced hemostasis in liver disease: a misunderstood coagulopathy"],"prefix":"10.1182","volume":"2021","author":[{"given":"Lara N.","family":"Roberts","sequence":"first","affiliation":[{"name":"King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"issue":"1","key":"2021121012080967800_hem2021000283C1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"issue":"6","key":"2021121012080967800_hem2021000283C2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0040-1714205","article-title":"Incidence of bleeding and thrombosis in patients with liver disease","volume":"46","author":"Roberts","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2021121012080967800_hem2021000283C3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ajg.2017.457","article-title":"Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER study","volume":"113","author":"Basili","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2021121012080967800_hem2021000283C4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1665-2681(19)31443-7","article-title":"A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients","volume":"11","author":"Shah","year":"2012","journal-title":"Ann Hepatol"},{"issue":"3","key":"2021121012080967800_hem2021000283C5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0038-1676981","article-title":"Incidence and recurrence of portal vein thrombosis in cirrhotic patients","volume":"119","author":"Violi","year":"2019","journal-title":"Thromb Haemost"},{"issue":"2","key":"2021121012080967800_hem2021000283C6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"2021121012080967800_hem2021000283C7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/apt.15137","article-title":"Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study","volume":"49","author":"Nery","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"2021121012080967800_hem2021000283C8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/liv.14121","article-title":"Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study","volume":"39","author":"Noronha Ferreira","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"2021121012080967800_hem2021000283C9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"Thromb Haemost"},{"key":"2021121012080967800_hem2021000283C10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcrc.2017.07.053","article-title":"Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic- liver failure","volume":"43","author":"Fisher","year":"2018","journal-title":"J Crit Care"},{"issue":"9","key":"2021121012080967800_hem2021000283C11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1538-7836.2010.03937.x","article-title":"Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy","volume":"8","author":"Gatt","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2021121012080967800_hem2021000283C12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"2021121012080967800_hem2021000283C13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"2021121012080967800_hem2021000283C14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/liv.12657","article-title":"Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis","volume":"35","author":"Reuken","year":"2015","journal-title":"Liver Int"},{"issue":"5","key":"2021121012080967800_hem2021000283C15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF01313579","article-title":"Bleeding after liver biopsy does not correlate with indices of peripheral coagulation","volume":"26","author":"Ewe","year":"1981","journal-title":"Dig Dis Sci"},{"issue":"9","key":"2021121012080967800_hem2021000283C16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cgh.2009.04.019","article-title":"A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation","volume":"7","author":"Vieira da Rocha","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021121012080967800_hem2021000283C17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2016.11.007","article-title":"Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia","volume":"38","author":"Napolitano","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"4","key":"2021121012080967800_hem2021000283C18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.12999","article-title":"Patterns of blood component use in cirrhosis: a nationwide study","volume":"36","author":"Desborough","year":"2016","journal-title":"Liver Int"},{"issue":"1","key":"2021121012080967800_hem2021000283C19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.dld.2018.06.003","article-title":"Management of haemostatic alterations and associated disorders in cirrhosis in Spain: a national survey","volume":"51","author":"Fortea","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"1","key":"2021121012080967800_hem2021000283C20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"2021121012080967800_hem2021000283C21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","author":"Gin\u00e9s","year":"1987","journal-title":"Hepatology"},{"issue":"5","key":"2021121012080967800_hem2021000283C22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2005.02387.x","article-title":"Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease","volume":"21","author":"Pache","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"2021121012080967800_hem2021000283C23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/liv.13712","article-title":"Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis","volume":"38","author":"Hung","year":"2018","journal-title":"Liver Int"},{"issue":"12","key":"2021121012080967800_hem2021000283C24","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/TP.0b013e318250fc25","article-title":"Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center","volume":"93","author":"Massicotte","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"2021121012080967800_hem2021000283C25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bjh.15167","article-title":"British Society of Haematology guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding","volume":"181","author":"Green","year":"2018","journal-title":"Br J Haematol"},{"issue":"2","key":"2021121012080967800_hem2021000283C26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/gut.15.2.99","article-title":"The portal pressure-blood volume relationship in cirrhosis","volume":"15","author":"Zimmon","year":"1974","journal-title":"Gut"},{"issue":"1","key":"2021121012080967800_hem2021000283C27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jhep.2019.09.008","article-title":"Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation","volume":"72","author":"Rassi","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"2021121012080967800_hem2021000283C28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jth.15185","article-title":"Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease","volume":"19","author":"von Meijenfeldt","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2021121012080967800_hem2021000283C29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/liv.12038","article-title":"Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion","volume":"33","author":"Tripodi","year":"2013","journal-title":"Liver Int"},{"issue":"10038","key":"2021121012080967800_hem2021000283C30","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"2021121012080967800_hem2021000283C31","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.30561","article-title":"Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2)","volume":"70","author":"Peck-Radosavljevic","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"2021121012080967800_hem2021000283C32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","article-title":"Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia","volume":"155","author":"Terrault","year":"2018","journal-title":"Gastroenterology"},{"key":"2021121012080967800_hem2021000283C33","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2020.1859102","article-title":"The efficacy and safety of thrombopoeitin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis","author":"Lindquist","year":"2021","journal-title":"Platelets"},{"issue":"1","key":"2021121012080967800_hem2021000283C34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"2021121012080967800_hem2021000283C35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical practice update: coagulation in cirrhosis","volume":"157","author":"O'Leary","year":"2019","journal-title":"Gastroenterology"},{"key":"2021121012080967800_hem2021000283C36","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","article-title":"Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions\u2014part II: recommendations","volume":"30 (8)","author":"Patel","year":"2019","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"2021121012080967800_hem2021000283C37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG clinical guideline: disorders of the hepatic and mesenteric circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2021121012080967800_hem2021000283C38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trre.2014.01.003","article-title":"Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up","volume":"28","author":"Ponziani","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"issue":"1","key":"2021121012080967800_hem2021000283C39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1160\/TH16-06-0450","article-title":"The risk of venous thromboembolism in patients with cirrhosis: a systematic review and meta-analysis","volume":"117","author":"Ambrosino","year":"2017","journal-title":"Thromb Haemost"},{"issue":"5","key":"2021121012080967800_hem2021000283C40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MEG.0000000000000325","article-title":"De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the model for end-stage liver disease scoring system","volume":"27","author":"Abdel-Razik","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"2021121012080967800_hem2021000283C41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/liv.13087","article-title":"Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis","volume":"36","author":"La Mura","year":"2016","journal-title":"Liver Int"},{"issue":"2","key":"2021121012080967800_hem2021000283C42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","article-title":"Current knowledge and management of portal vein thrombosis in cirrhosis","volume":"75","author":"Senzolo","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"2021121012080967800_hem2021000283C43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12325-020-01550-4","article-title":"Anticoagulation favors thrombus recanalization and survival in patients with liver cirrhosis and portal vein thrombosis: results of a meta-analysis","volume":"38","author":"Wang","year":"2021","journal-title":"Adv Ther"},{"issue":"5","key":"2021121012080967800_hem2021000283C44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5604\/01.3001.0012.0775","article-title":"Low fibrinogen levels are associated with bleeding after varices ligation in thrombocytopenic cirrhotic patients","volume":"17","author":"Giannini","year":"2018","journal-title":"Ann Hepatol"},{"issue":"7","key":"2021121012080967800_hem2021000283C45","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/liv.13728","article-title":"Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients","volume":"38","author":"Bianchini","year":"2018","journal-title":"Liver Int"},{"issue":"7","key":"2021121012080967800_hem2021000283C46","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"19","key":"2021121012080967800_hem2021000283C47","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"2021121012080967800_hem2021000283C48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2018.08.011","article-title":"Direct oral anticoagulants in patients with liver cirrhosis: a systematic review","volume":"170","author":"Hoolwerf","year":"2018","journal-title":"Thromb Res"},{"key":"2021121012080967800_hem2021000283C49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vph.2018.05.002","article-title":"Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis","volume":"113","author":"Hanafy","year":"2019","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"2021121012080967800_hem2021000283C50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoki","year":"2018","journal-title":"Hepatol Res"},{"issue":"11","key":"2021121012080967800_hem2021000283C51","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/TP.0b013e31826e8e53","article-title":"Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review","volume":"94","author":"Rodr\u00edguez-Castro","year":"2012","journal-title":"Transplantation"},{"issue":"7","key":"2021121012080967800_hem2021000283C52","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J Thromb Haemost"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/485\/1851749\/485roberts.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/485\/1851749\/485roberts.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:17:36Z","timestamp":1639138656000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2021\/1\/485\/482988\/Rebalanced-hemostasis-in-liver-disease-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,10]]},"published-print":{"date-parts":[[2021,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2021000283","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,10]]},"published":{"date-parts":[[2021,12,10]]}}}